• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥氮平引起的非典型抗精神病药恶性综合征。

Atypical neuroleptic malignant syndrome caused by olanzapine.

作者信息

Nielsen J, Bruhn A M

机构信息

Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aalborg, Denmark.

出版信息

Acta Psychiatr Scand. 2005 Sep;112(3):238-40; discussion 240. doi: 10.1111/j.1600-0447.2005.00578.x.

DOI:10.1111/j.1600-0447.2005.00578.x
PMID:16095481
Abstract

OBJECTIVE

Neuroleptic malignant syndrome (NMS) is a rare syndrome with four main symptoms: rigidity, hyperthermia, altered mental status and autonomic instability. We report a patient with an atypical manifestation of NMS.

METHOD

A single case was reported.

RESULTS

A patient with pneumonia developed delirium and was treated with olanzapine and developed a NMS with fluctuating hyperthermia and autonomic instability during a month. Only slight rigidity was present. Creatine kinase was not elevated. The patient was severely agitated and manic. After discontinuation of olanzapine the patient showed no psychopathology or hyperthermia.

CONCLUSION

NMS should be considered when patients treated with antipsychotics develop one or more symptoms of NMS.

摘要

目的

抗精神病药恶性综合征(NMS)是一种罕见综合征,有四个主要症状:强直、高热、精神状态改变和自主神经功能不稳定。我们报告1例有非典型表现的NMS患者。

方法

报告1例个案。

结果

1例肺炎患者出现谵妄,接受奥氮平治疗,1个月内出现体温波动和自主神经功能不稳定的NMS。仅存在轻微强直。肌酸激酶未升高。患者极度烦躁和躁狂。停用奥氮平后,患者未出现精神病理学症状或高热。

结论

使用抗精神病药治疗的患者出现NMS的一种或多种症状时,应考虑NMS。

相似文献

1
Atypical neuroleptic malignant syndrome caused by olanzapine.奥氮平引起的非典型抗精神病药恶性综合征。
Acta Psychiatr Scand. 2005 Sep;112(3):238-40; discussion 240. doi: 10.1111/j.1600-0447.2005.00578.x.
2
Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.奥氮平所致抗精神病药恶性综合征的非典型表现
Indian J Med Sci. 2007 Oct;61(10):570-3.
3
Neuroleptic malignant syndrome due to olanzapine.奥氮平所致的抗精神病药恶性综合征
Psychopharmacol Bull. 2001 Summer;35(3):49-54.
4
Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.与近期抗精神病药引起的神经阻滞剂恶性综合征病史相关,使用丙氯拉嗪引起的神经阻滞剂恶性综合征。
Ann Pharmacother. 2011 Nov;45(11):e61. doi: 10.1345/aph.1Q325. Epub 2011 Oct 4.
5
Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.在接受利伐斯的明联合治疗的患者中出现的奥氮平相关性抗精神病药恶性综合征。
Pharmacotherapy. 2008 Mar;28(3):403-5. doi: 10.1592/phco.28.3.403.
6
[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].[抗精神病药恶性综合征与非典型抗精神病药物:简要综述]
Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2.
7
[Neuroleptic malignant syndrome after treatment with olanzapine].奥氮平治疗后发生的神经阻滞剂恶性综合征
Ugeskr Laeger. 1999 Mar 8;161(10):1424-5.
8
Neuroleptic malignant syndrome associated with olanzapine.与奥氮平相关的抗精神病药恶性综合征。
Ann Pharmacother. 1998 Nov;32(11):1158-9. doi: 10.1345/aph.18151.
9
Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature.抗精神病药物治疗内科及外科患者谵妄或躁动时并发的神经阻滞剂恶性综合征:病例报告及文献综述
Psychosomatics. 2009 Jan-Feb;50(1):8-15. doi: 10.1176/appi.psy.50.1.8.
10
Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.奥氮平与左美丙嗪治疗期间出现的抗精神病药恶性综合征
Acta Psychiatr Scand. 2000 Sep;102(3):231-3. doi: 10.1034/j.1600-0447.2000.102003231.x.

引用本文的文献

1
Neuroleptic Malignant Syndrome Improved with Intramuscular Administration of the Anticholinergic Agent, Biperiden.抗胆碱能药物比哌立登肌肉注射改善了抗精神病药恶性综合征
Int Med Case Rep J. 2023 May 12;16:281-286. doi: 10.2147/IMCRJ.S412619. eCollection 2023.
2
Development of Neuroleptic Malignant Syndrome in a Patient with Lewy Body Dementia after Intramuscular Administration of Paliperidone.利培酮肌内注射后路易体痴呆患者发生抗精神病药恶性综合征
Case Rep Neurol Med. 2021 Jan 13;2021:8879333. doi: 10.1155/2021/8879333. eCollection 2021.
3
A Neuroleptic Malignant Syndrome Without Rigidity.
一种无强直的抗精神病药恶性综合征。
Psychiatry Investig. 2018 Feb;15(2):226-229. doi: 10.30773/pi.2017.06.05. Epub 2017 Dec 14.
4
Olanzapine-Induced Neuroleptic Malignant Syndrome.奥氮平所致的抗精神病药恶性综合征
Iran J Med Sci. 2017 May;42(3):306-309.
5
Olanzapine-Induced Malignant Neuroleptic Syndrome.奥氮平所致恶性抗精神病综合征
Turk J Anaesthesiol Reanim. 2014 Oct;42(5):288-91. doi: 10.5152/TJAR.2014.46704. Epub 2014 Jul 9.
6
Olanzapine-induced atypical neuroleptic malignant syndrome in an adolescent man with anorexia nervosa.奥氮平诱发一名患有神经性厌食症的青少年男性出现非典型抗精神病药恶性综合征。
Eat Weight Disord. 2016 Jun;21(2):309-11. doi: 10.1007/s40519-015-0247-3. Epub 2015 Nov 25.
7
Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.第二代抗精神病药物与神经阻滞剂恶性综合征:系统评价与病例报告分析
Drugs R D. 2015 Mar;15(1):45-62. doi: 10.1007/s40268-014-0078-0.
8
A rare case of neuroleptic malignant syndrome without elevated serum creatine kinase.一例神经阻滞剂恶性综合征,血清肌酸激酶未升高。
Neuropsychiatr Dis Treat. 2014 Feb 24;10:403-7. doi: 10.2147/NDT.S58677. eCollection 2014.
9
Case reports of neuroleptic malignant syndrome in context of quetiapine use.喹硫平使用相关的神经阻滞剂恶性综合征病例报告。
Psychiatr Q. 2013 Dec;84(4):523-41. doi: 10.1007/s11126-013-9264-4.
10
Pharmacological and nonpharmacological management of delirium in critically ill patients.危重症患者谵妄的药物和非药物管理。
Neurotherapeutics. 2012 Jan;9(1):158-75. doi: 10.1007/s13311-011-0102-9.